Santos-Rosa, H.* ; Millán-Zambrano, G.* ; Han, N.* ; Leonardi, T.* ; Klimontova, M.* ; Nasiscionyte, S. ; Pandolfini, L.* ; Tzelepis, K.* ; Bartke, T. ; Kouzarides, T.*
Methylation of histone H3 at lysine 37 by Set1 and Set2 prevents spurious DNA replication.
Mol. Cell 81, 2793-2807.e8 (2021)
DNA replication initiates at genomic locations known as origins of replication, which, in S. cerevisiae, share a common DNA consensus motif. Despite being virtually nucleosome-free, origins of replication are greatly influenced by the surrounding chromatin state. Here, we show that histone H3 lysine 37 mono-methylation (H3K37me1) is catalyzed by Set1p and Set2p and that it regulates replication origin licensing. H3K37me1 is uniformly distributed throughout most of the genome, but it is scarce at replication origins, where it increases according to the timing of their firing. We find that H3K37me1 hinders Mcm2 interaction with chromatin, maintaining low levels of MCM outside of conventional replication origins. Lack of H3K37me1 results in defective DNA replication from canonical origins while promoting replication events at inefficient and non-canonical sites. Collectively, our results indicate that H3K37me1 ensures correct execution of the DNA replication program by protecting the genome from inappropriate origin licensing and spurious DNA replication.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
H3k37methylation ; Histone Modifications ; Mcm ; Origin Licensing ; Replication Origins ; Set1 ; Set2; Compass Family; Origin; Initiation; Proteins; Yeast; Acetylation; Chromatin; Program; Methyltransferase; Reveals
Keywords plus
Language
english
Publication Year
2021
Prepublished in Year
HGF-reported in Year
2021
ISSN (print) / ISBN
1097-2765
e-ISSN
1097-4164
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 81,
Issue: 13,
Pages: 2793-2807.e8
Article Number: ,
Supplement: ,
Series
Publisher
Elsevier
Publishing Place
50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30203 - Molecular Targets and Therapies
Research field(s)
Helmholtz Diabetes Center
PSP Element(s)
G-502800-001
Grants
Helmholtz Association
European Research Council (ERC)
Sir Henry Wellcome Fellowship
Asociacion Espanola Contra el Cancer
European Molecular Biology Organization (EMBO)
Wellcome Trust
Cancer Research UK
Copyright
Erfassungsdatum
2021-06-18